Fuda Cancer Hospital
Leukemia chemotherapy in China typically costs from $16,500 to $38,000. The final price depends on the hospital type, drug selection, and treatment phase. In the US, similar procedures cost around $35,000 on average. Patients save around 53% compared to US prices. Standard international packages often include diagnostics, initial chemotherapy cycles, and hospital stays.
Bookimed Expert Insight: China offers high-value options for complex blood diseases at JCI-accredited facilities. Fuda Cancer Hospital in Guangzhou is world-renowned for late-stage cancer treatment. Lu Daopei Hematology Hospital in Beijing provides specialized care for refractory leukemia. Beijing Kyoto Children's Hospital focuses on high-risk pediatric cases. Choosing these specialized hubs ensures access to experienced hematologists and advanced protocols.
| China | Turkey | Austria | |
| Leukemia chemotherapy | from $16,500 | from $8,000 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Leukemia chemotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Leukemia chemotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Leukemia chemotherapy journey.
Day 1
Day 2
Day 3
Day 4 - Day 10 (Treatment Days)
Day 11 - Day 14 (Post-Treatment)
Week 2 - Week 4 (Rehabilitation)
Please note that each patient"s recovery timeline may vary based on individual circumstances and the severity of the disease.
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
The doctor is a renowned expert in minimally invasive cryosurgery for cancer, serving as President and chief surgeon at Fuda Cancer Hospital since 2001. With a focus on oncology and minimally invasive procedures, the doctor has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures, treating patients aged 4 to 94.
Graduating from The Fourth Military Medical University with a specialty in thoracic and cardiac surgery, the doctor has contributed significantly to the field with over 100 published papers. Recognized with awards for outstanding contributions to cryosurgery, the doctor holds vice-presidential roles in both the Asian and International Societies of Cryosurgery.